Back
Nektar Therapeutics Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
32
NKTR
Nektar Therapeutics
Last Price:
$37.34
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.78 | Buy |
| 20-day SMA: | 38.47 | Sell |
| 50-day SMA: | 47.49 | Sell |
| 200-day SMA: | 35.24 | Buy |
| 8-day EMA: | 14.38 | Buy |
| 20-day EMA: | 6.59 | Buy |
| 50-day EMA: | 2.79 | Buy |
| 200-day EMA: | 0.72 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.15 | Buy |
| Relative Strength Index (14 RSI): | 41.15 | Sell |
| Chaikin Money Flow: | 825387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Nektar Therapeutics Technical Analysis
| Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 37.33 while NKTR 8-day simple moving average is 36.78, which is a Buy signal.
-
The stock price of NKTR is 37.33 while Nektar Therapeutics 20-day SMA is 38.47, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 47.49 while NKTR share price is 37.33, making it a Sell technically.
-
NKTR stock price is 37.33 and Nektar Therapeutics 200-day simple moving average is 35.24, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
32
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $37.33. The Score for NKTR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
645.8M
Price in USD:
37.33
Share Volume:
995.5K
Nektar Therapeutics 52-Week Range
52-Week High:
66.92
52-Week Low:
6.48
Sell
32
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 37.33 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 37.33 while NKTR 8-day exponential moving average is 14.38, which is a Buy signal.
-
The stock price of NKTR is 37.33 while Nektar Therapeutics 20-day EMA is 6.59, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 2.79 while NKTR share price is 37.33, making it a Buy technically.
-
NKTR stock price is 37.33 and Nektar Therapeutics 200-day simple moving average is 0.72, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 5.15, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 41.15, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is ( - ), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is ( - ), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.